May. 29. 2026Blog
Exhibition Report : INTERPHEX Week TOKYO2026 / Regenerative Medicine EXPO
From May 20 to 22, 2026, TEIJIN REGENET Co., Ltd and J-TEC jointly exhibited at the Regenerative Medicine Expo, held as part of INTERPHEX Week Tokyo 2026. We were pleased to welcome visitors to our booth.
Thank you very much for taking the time to visit us despite the rain!
▼ Number of visitors to INTERPHEX *[Excerpted from the INTERPHEX website]
At the booth, we introduced TEIJIN REGENET with a focus on the following points:
●A Regenerative Medicine CDMO Providing Integrated Development and Manufacturing Support
TEIJIN REGENET supports a wide range of modalities, including CAR-T, iPS cells, and MSCs, and provides integrated support from early-stage development through commercial manufacturing. Leveraging our record of collaboration with J-TEC, as well as our strengths in quality and regulatory compliance, we support the social implementation of regenerative medicine products.
●Global Expansion Through Domestic and International Networks and the Development of Co-Trial Lab
In addition to our three domestic sites—Kashiwanoha, Iwakuni, and J-TEC—we are collaborating with overseas partners in Singapore, the United States, Australia, and other regions to build a global development and manufacturing infrastructure in the field of regenerative medicine. As part of our initiatives to support the regenerative medicine ecosystem, we have also launched “Co-Trial Lab,” a firsthand support service that makes use of cell culture rooms and other facilities, thereby strengthening our support framework from the preliminary stages of development.
●Commercialization Support Through “Beyond CDMO”
Going beyond contract manufacturing, we promote early commercialization for startups and biotech ventures as a “Beyond CDMO” partner, with strengths in regulatory support, business development support, and launch support including MAH matching.
TEIJIN REGENET will continue to provide CDMO services that offer seamless support tailored to each client, from research and development of regenerative medicine products to business plan formulation and commercial manufacturing.
If you have any questions or would like to discuss your needs, please feel free to contact us.
